[Federal Register Volume 73, Number 113 (Wednesday, June 11, 2008)]
[Page 33094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-13043]



Centers for Disease Control and Prevention

Advisory Board on Radiation and Worker Health (ABRWH or Advisory 
Board), National Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 

    Board Meeting Times and Dates (All times are Central Daylight 
    9 a.m.-5 p.m., June 24, 2008.
    9 a.m.-5 p.m., June 25, 2008.
    9 a.m.-2 p.m., June 26, 2008.
    Public Comment Times and Dates (All times are Central Daylight 
    5 p.m.-6 p.m., June 24, 2008.
    7:30 p.m.-8:30 p.m., June 25, 2008.
    Place: Millennium Hotel St. Louis, 200 South 4th Street, St. 
Louis, MO 63102, Telephone (314) 241-9500, Fax (314) 516-6149.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 75 to 100 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program (EEOICP) Act of 
2000 to advise the President on a variety of policy and technical 
functions required to implement and effectively manage the new 
compensation program. Key functions of the Advisory Board include 
providing advice on the development of probability of causation 
guidelines which have been promulgated by the Department of Health 
and Human Services (HHS) as a final rule, advice on methods of dose 
reconstruction which have also been promulgated by HHS as a final 
rule, advice on the scientific validity and quality of dose 
estimation and reconstruction efforts being performed for purposes 
of the compensation program, and advice on petitions to add classes 
of workers to the Special Exposure Cohort (SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements 
this responsibility for CDC. The charter was issued on August 3, 
2001, renewed at appropriate intervals, and will expire on August 3, 
    Purpose: This Advisory Board is charged with (a) providing 
advice to the Secretary, HHS, on the development of guidelines under 
Executive Order 13179; (b) providing advice to the Secretary, HHS, 
on the scientific validity and quality of dose reconstruction 
efforts performed for this program; and (c) upon request by the 
Secretary, HHS, advise the Secretary on whether there is a class of 
employees at any Department of Energy facility who were exposed to 
radiation but for whom it is not feasible to estimate their 
radiation dose, and on whether there is reasonable likelihood that 
such radiation doses may have endangered the health of members of 
this class.
    Matters to be Discussed: The agenda for the Advisory Board 
meeting includes: NIOSH Program Status Update; Special Exposure 
Cohort (SEC) Petitions for: Y-12 Plant, Dow Chemical Company, and 
Spencer Chemical Company; SEC Petition Updates: Chapman Valve, Rocky 
Flats Plant, Blockson Chemical Company, Area IV of the Santa Susana 
Field Laboratory, Massachusetts Institute of Technology (MIT), Texas 
City Chemicals; Presentation by the Office of Compensation Analysis 
and Support (OCAS) on special science journal publication; a 
presentation on Board interactions with Congressional staffers; 
Department of Labor (DOL) Update; Department of Energy (DOE) Update 
including data access and security; Work Group reports; Subcommittee 
on Dose Reconstruction Reviews Report; and Board Future Plans and 
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may 
be submitted according to the policy provided below. Any written 
comments received will be provided at the meeting and should be 
submitted to the contact person below well in advance of the 
    Policy on Redaction of Board Meeting Transcripts (Public 
Comment), (1) If a person making a comment gives his or her name, no 
attempt will be made to redact that name. (2) NIOSH will take 
reasonable steps to ensure that individuals making public comment 
are aware of the fact that their comments (including their name, if 
provided) will appear in a transcript of the meeting posted on a 
public Web site. Such reasonable steps include: (a) A statement read 
at the start of each public comment period stating that transcripts 
will be posted and names of speakers will not be redacted; (b) A 
printed copy of the statement mentioned in (a) above will be 
displayed on the table where individuals sign up to make public 
comment; (c) A statement such as outlined in (a) above will also 
appear with the agenda for a Board Meeting when it is posted on the 
NIOSH Web site; (d) A statement such as in (a) above will appear in 
the Federal Register Notice that announces Board and Subcommittee 
meetings. (3) If an individual in making a statement reveals 
personal information (e.g., medical information) about themselves 
that information will not usually be redacted. The NIOSH FOIA 
coordinator will, however, review such revelations in accordance 
with the Freedom of Information Act and the Federal Advisory 
Committee Act and if deemed appropriate, will redact such 
information. (4) All disclosures of information concerning third 
parties will be redacted. (5) If it comes to the attention of the 
DFO that an individual wishes to share information with the Board 
but objects to doing so in a public forum, the DFO will work with 
that individual, in accordance with the Federal Advisory Committee 
Act, to find a way that the Board can hear such comments.
    Contact Person for More Information: Christine Branche, PhD, 
Executive Secretary, NIOSH, CDC, 395 E. Street, SW., Suite 9200, 
Washington, DC 20201, Telephone (513) 533-6800, Toll Free 1 (800) 
35-NIOSH, E-mail [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 4, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E8-13043 Filed 6-10-08; 8:45 am]